Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 5.24 is 291% above its 5-year average of -2.74, near the high end of its 5-year range (-324.63–135.67).
As of the fiscal period ended Saturday, July 4, 2026. 86.47% below its 12-month average of 38.74.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-07-04): 5.24.
DEBT TO EQUITY RATIO
5.24
DEBT TO EQUITY RATIO AVG TTM
38.74
DEBT TO EQUITY RATIO AVG 3Y
-5.85
DEBT TO EQUITY RATIO AVG 5Y
-2.74
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-86.47%
CURRENT VS 3Y AVG
+189.55%
CURRENT VS 5Y AVG
+291.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 718 covered companies
CURRENT VS SECTOR MEDIAN
+4663.51%
vs the sector median at left
Aveanna Healthcare Holdings Inc.
Market Cap
$2.67B
Debt to Equity Ratio
5.24
TTM Avg
38.74
3Y Avg
-5.85
5Y Avg
-2.74
Market Cap
$2.67B
Debt to Equity Ratio
0.38
TTM Avg
0.41
3Y Avg
0.35
5Y Avg
0.23
Market Cap
$2.66B
Debt to Equity Ratio
1.30
TTM Avg
1.02
3Y Avg
0.78
5Y Avg
0.91
Market Cap
$2.66B
Debt to Equity Ratio
0.01
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$2.58B
Debt to Equity Ratio
0.23
TTM Avg
0.23
3Y Avg
0.22
5Y Avg
0.25
Market Cap
$2.58B
Debt to Equity Ratio
0.01
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
0.07
Market Cap
$2.55B
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aveanna Healthcare Holdings Inc. (AVAH) | $2.67B | 5.24 | 38.74 | -5.85 | -2.74 |
| Neogen Corporation (NEOG)vs › | $2.67B | 0.38 | 0.41 | 0.35 | 0.23 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.66B | 1.30 | 1.02 | 0.78 | 0.91 |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.66B | 0.01 | 0.00 | 0.00 | 0.00 |
| Precigen, Inc. (PGEN)vs › | $2.72B | 2.26 | 2.42 | 1.33 | 1.63 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.58B | 0.23 | 0.23 | 0.22 | 0.25 |
| Privia Health Group, Inc. (PRVA)vs › | $2.58B | 0.01 | 0.01 | 0.01 | 0.07 |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.55B | 0.00 | 0.00 | 0.00 | 0.00 |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 0.14 | 0.17 | 0.17 | 0.17 |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | 1.67 | 1.63 | 1.85 | 1.39 |
Debt/Equity
5.24
Current Ratio
1.16
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-07-04 | 5.24 |
| 2026-04-04 | 6.26 |
| 2026-01-03 | 7.79 |
| 2025-09-27 | 135.67 |
| 2025-06-28 | -132.41 |
| 2025-03-29 | -13.42 |
| 2024-12-28 | -10.92 |
| 2024-09-28 | -8.60 |
| 2024-06-29 | -11.36 |
| 2024-03-30 | -9.98 |
| 2023-12-30 | -10.55 |
| 2023-09-30 | -12.97 |
| 2023-07-01 | -292.26 |
| 2023-04-01 | -44.57 |
| 2022-12-31 | -324.63 |
| 2022-10-01 | 5.86 |
| 2022-07-02 | 6.43 |
| 2022-04-02 | 1.93 |
| 2022-01-01 | 2.04 |
| 2021-10-02 | 1.18 |
| 2021-07-03 | 1.20 |
| 2021-04-03 | 4.48 |
| 2020-12-31 | 4.60 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
